Institutional investors hold a majority ownership of GWPH through the 75.22% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2016, these large investors purchased a net $1.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SCOPIA CAPITAL MANAGEMENT LP Bought 1.2 Million shares of GW Pharmaceuticals PLC
CUTLER GROUP LP Bought 22.1 Thousand shares of GW Pharmaceuticals PLC